Production restructuring in pharmaceutical companies to propel fine chemicals market in North America

The increasing focus of pharmaceutical companies on research and development as well as their reduced emphasis on captive manufacturing are driving the fine chemicals market in North America. Fine chemicals suppliers offer products at lower costs, reduce marketing time, as well as enable pharma companies to focus on their core competencies and employ beneficial reorganization processes.